High-Flow Needleless Valve and DualCap Disinfection Devices Associate With Catheter-related Bloodstream Infection

The Effect of High-Flow Needleless Valve and DualCap Disinfection Devices on Incidence of Catheter-related Bloodstream Infection in Hemodialysis Patients: a Single Center Randomized Controlled Trial

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02990923

Enrollment

102

Registered

2016-12-13

Start date

2016-12-31

Completion date

Unknown

Last updated

2016-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related Bloodstream Infection

Brief summary

The purpose of this study is to investigate whether the usage of High-Flow Needleless Valve and DualCap Disinfection Devices would reduce the incidence of catheter-related bloodstream infection in hemodialysis patients.

Interventions

DEVICEHigh-Flow Needleless Valve

DEVICEDualCap Disinfection Devices

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Implanted non-tunneled cuff catheter for any reason and going on blood purified therapy in our centre * Have signed information consent form

Exclusion criteria

* Have got bacteremia before catheter implantation * Catheter changing in situ

Design outcomes

Primary

Measure	Time frame
Catheter-related bloodstream infection	through study completion, an average of 1 year

Secondary

Measure	Time frame
Number of participants with catheter withdraw for any reason	through study completion, an average of 1 year
Number of participants with catheter dysfunction	through study completion, an average of 1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026